KUALA LUMPUR, Kolmar BNH, a Korean health functional food Original Development Manufacturing (ODM) firm, has sped up its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena.
HemoHIM G (Global) is the international version of ‘HemoHIM’, Korea’s first individually-approved immune-boosting health supplement developed by Kolmar BNH over an eight-year period.
According to Kolmar BNH in a statement, the formulation has been tailored to comply with the food regulations of various countries, with adjustments made to raw materials and ingredient ratios.
The product features angelica sinensis, ligusticum chuanxiong, paeonia lactiflora, all selected through rigorous quality control processes, in which its enhanced taste and aroma also make HemoHIM G more appealing to a broader audience.
Distributed by Atomy, HemoHIM is Kolmar BNH’s technologically-advanced product and is currently available in 19 countries, including Australia, the United States, Th
ailand, Central Asia, and South America.
Kolmar BNH continues its efforts in research and development (RandD) to enhance HemoHIM’s global competitiveness including new functionalities, through investing about four per cent of its annual revenues to RandD.
Leveraging the competitive edge of HemoHIM G, the company plans to speed up exports to European countries, including Turkey, Italy, and Belgium.
In June, the company published a study showing that the main ingredient of HemoHIM has antioxidant and anti-fatigue effects, which are newly discovered, in the issue of the ‘Journal of Medicinal Food’, a Science Citation Index Expanded (SCIE)-level international journal.
Source: BERNAMA News Agency
